Wow. Jaw droppingly great talk 🗣️delivered by the one & only Pam R. Taub, MD❤️💃🏻 on how mitochondrial fcn underlies cardiometabolic syndrome, POTS & long-COVID. 🫀Prevention & #FunctionNotFailure are inextricably linked!!!

Humble brilliance at its finest 🙌🏽 Mount Sinai Fuster Heart Hospital Dr. Deepak L. Bhatt

Just thinking back to #ACC2024 … So proud of all our members who showcased their incredible work

Thrilled to announce #JACCHF award for Outstanding Scholarship named in honor of Inova Schar Heart and Vascular President Christopher O'Connor
In recognition of his outstanding 10 year service as founding Editor-in-Chief. Congratulations

#ACC2024 American College of Cardiology

We are proud to honor U.S. FDA Commissioner Robert M. Califf, MD, MACC Dr. Robert M. Califf with this year's Presidential Citation Award, for his work prioritizing science & evidence-based policymaking in the best interests of patients and the public. bit.ly/4aqox9k #ACC24

That’s a wrap #ACC24 ! What a meeting!!!! Douglas Drachman & katie berlacher thank you & American College of Cardiology staff & prgrm committee for all your hard work!! Wonderful sharing science, being inspired, & connecting w/friends, colleagues & mentors! ☀️🙏🏽🫀

Now, ✈️time to hug my fam!

How can we call attention to the lack of diversity in clinical trials at a Congressional level?

Megha Gupta presents at #ACC2024 on the HFC Letter to Congress to reconsider demographic legislation and the HFC recommendations to enhance underrepresented enrollment in HF trials

ICYMI: Dr. James Januzzi Jr MD is spotlighting his groundbreaking #JACC late-breaking clinical trial, the ARISE-HF trial.

Dive into the full paper here for all the details: bit.ly/49xfMcq

#ACC24 #Diabetes #HeartFailure #ARISE #Cardiology #ACCessPoints

Now online JACC Journals, primary results of the #ARISE -HF clinical trial of aldose reductase inhibitor treatment with AT-001 for patients with #DiabeticCardiomyopathy

#ACC24 #ACC2024 American College of Cardiology

secure-web.cisco.com/14PRHiPQwkwSfl…

#ACC24 #SimPub by Alberto Foà in JACC Journals

Fascinating observation from #PARAGONHF — pts w LVEF above 60% were at *higher* risk of hypotension & *lower* likelihood of benefit w #ARNI sacubitril/valsartan

Reinforces current guidance for pt selection

jacc.org/doi/10.1016/j.…

Beautiful deep dive discussion on #EMPACT_MI by Robert Mentz, MD #ACC24

So…would you use SGLT2i post MI?

Javed Butler responds:
If indication (HF, DM, CKD) go ahead and get started!
If a revascularized STEMI pt & no other major issue, probably ok not to start in acute setting!

Great insights from ISABELLA CAVAGNA at #ACC2024 today about the impact of #ClinicalTrial demographics on early adoption of breakthrough #MedTech .

Now available in JACC Journals: sciencedirect.com/science/articl…

US Safety Info: bit.ly/3TVOnfL

How can we utilize community organizations to improve diversity in clinical trials?

Yasmire Shardae Presenting on how HFC and National Pan-Hellenic Councils can bring awareness to Black patients and underserved communities of the critical lack of diversity in HF clinical trials.

#ACC24 #SimPub in #EJHF by Ankeet S. Bhatt, MD, MBA

Highlighted Original Research in #HF / #Cardiomyopathy Year in Review

#ARNI associated with lower risk of all-cause and CV hospitalizations compared with #RASi in US real world cohort of pts with HF & LVEF>40%

onlinelibrary.wiley.com/doi/abs/10.100…

The EMPACT-MI study presented by @javedbutler1 at #ACC24 found that use of the #SGLT2 empagliflozin did not reduce mortality after a #HeartAttack but did reduce the risk of #HeartFailure after heart attack. #CardioX bit.ly/3xkPYmm Baylor Scott & White Health

#SimPub in JACC Journals
Does HF trial enrollment contribute to underutilization of therapies among diverse groups in clinical practice?

HFC Intern ISABELLA CAVAGNA presents on Clinical Trial Inclusion manuscript out now at the link below🔗
sciencedirect.com/science/articl…

Great start to ACC Day 1!

We love to see lots of HFC member activity with Dr. Abraham presenting on hemodynamics, Drs. Lala, Vardeny, and Marat serving on the Young Investigators Award panel, and Drs. Butler, Januzzi, and Bozkurt on Late Breaking HF Trials!

Good morning and welcome to Atlanta!

On behalf of the ACC, thank you for taking time out of your personal and professional lives to join us for a celebration to remember! -- B. Hadley Wilson MD #ACC24

Happy birthday to HFC Intern Megha Gupta 🎊🥳 What a great way to celebrate at your first ACC conference!

Don’t miss HFC in action at DAY 1 of #ACC24

Here are some of our member highlight…
American College of Cardiology JACC Journals

Excited for #ACC24 this weekend! Don't miss my presentation on “Cardiometabolic risk factor burden and circulating biomarkers in patients with chronic coronary disease in the ISCHEMIA Trials' on Sunday, April 7 at 10:15 at Hall B4-5. #Cardiology #ACC24 NYU Langone Health NYU Grossman School of Medicine